DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Llombart-Cussac A, Pérez-García JM, Bellet M. et al.
PARSIFAL: A randomized, multicenter, open-label, phase II trial to evaluate palbociclib in combination with fulvestrant or letrozole in endocrine-sensitive patients with estrogen receptor (ER)[+]/HER2[−] metastatic breast cancer.
J Clin Oncol 2020;
38: 1007-1007
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.